Versant Ventures
Angela is based in Toronto and is building on our track record of launching newcos in Canada. She brings particular expertise in the fields of regenerative medicine and stem cell biology. Angela joins us from McKinsey where she worked extensively with private equity, biotech and pharma clients on projects spanning R&D operations, corporate strategy and due diligence.
This person is not in any offices
Versant Ventures
1 followers
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.